Environmental Committee Sample Clauses

Environmental Committee. The objective of this Committee is to recommend and explore various ways in which Air Transat can reduce their environmental footprint.
AutoNDA by SimpleDocs
Environmental Committee. The Employer is committed to acting in a responsible manner towards the environment and recognise that such actions lead to a safe, secure working environment. The Employer will be responsible for monitoring and implementing environment performance on the work site in consultation with its employees.
Environmental Committee. The Company agrees to establish a Joint Environmental Committee consisting of two (2) hourly employees and two (2) salaried employees. The parties agreed that environmental issues and statistics pertaining to Canadian Fabricated Products are to be held confidential if so requested. The Committee shall meet three (3) times annually at mutually agreeable times and place to review and discuss issues involv- ing the environment, recycling and energy conservation which pertain to Canadian Fabricated Products employees.
Environmental Committee. As of the Effective Date, Solutia and Monsanto shall have established a committee (the “Environmental Committee”) to oversee Solutia’s Environmental Remediation with respect to the Shared Sites in accordance with the charter, attached hereto as Exhibit I (the “Charter”), which may be amended by the agreement of the Parties from time to time. The initial Charter shall include the following provisions:
Environmental Committee. Purchaser and GM will establish an Environmental Committee to facilitate environmental transition issues. The Environmental Committee will:
Environmental Committee. Purchaser and GM agree that the Environmental Committee established under Section 7.6.3 will also facilitate environmental transition issues in relation to the Non-US Properties and the Short Presence Properties.

Related to Environmental Committee

  • Management Committee The Members shall act collectively through meetings as a "committee of the whole," which is hereby named the "Management Committee." The Management Committee shall conduct its affairs in accordance with the following provisions and the other provisions of this Agreement:

  • Operating Committee the Consortium’s managing body, composed of representatives of the Manager and the Contractors, pursuant to Annex XI.

  • Development Committee As soon as practicable, the Parties will establish a joint development committee, comprised of at least one (1) and up to two (2) representatives of Omega and at least one (1) and up to two (2) representatives of Acuitas (the “JDC”). One such representative from each Party will be such Party’s Workplan Leader. Each Party may replace its Workplan Leader and other JDC representatives at any time upon written notice to the other Party, provided, however, that each Party shall use reasonable efforts to ensure continuity on the JDC. With the consent of the other Party (which will not be unreasonably withheld, conditioned or delayed), each Party may invite non-voting employees and consultants to attend JDC meetings as necessary, subject to consultant’s agreement to be bound to the same extent as a permitted subcontractor under Section 3.1(i).

  • Advisory Committee The Settling State shall designate an Opioid Settlement Remediation Advisory Committee (the “Advisory Committee”) to provide input and recommendations regarding remediation spending from that Settling State’s Abatement Accounts Fund. A Settling State may elect to use an existing advisory committee or similar entity (created outside of a State-Subdivision Agreement or Allocation Statute); provided, however, the Advisory Committee or similar entity shall meet the following requirements:

  • Special Committee The term “Special Committee” shall have the meaning as provided in Section 13(a).

  • Authority of the Committee The Committee shall have full authority to interpret and construe the terms of the Plan and this Agreement. The determination of the Committee as to any such matter of interpretation or construction shall be final, binding and conclusive.

  • Transition Committee 8.1.0 A transition committee comprised of the employee representatives and the employer representatives, including the Crown, will be established by January 31, 2016 to address all matters that may arise in the creation of the Trust.

  • Joint Development Committee The Parties shall form a joint development committee (the “Joint Development Committee” or “JDC”), made up of an equal number of representatives of Merck and BioLineRx, which shall have responsibility of coordinating all regulatory and other activities under, and pursuant to, this Agreement. Each Party shall designate a project manager (the “Project Manager”) who shall be responsible for implementing and coordinating activities, and facilitating the exchange of information between the Parties, with respect to the Study. Other JDC members will be agreed by both Parties. The JDC shall meet as soon as practicable after the Effective Date and then no less than twice yearly, and more often as reasonably considered necessary at the request of either Party, to provide an update on the progress of the Study. The JDC may meet in person or by means of teleconference, Internet conference, videoconference or other similar communications equipment. Prior to any such meeting, the BioLineRx Project Manager shall provide an update in writing to the Merck Project Manager, which update shall contain information about the overall progress of the Study, recruitment status, interim analysis (if results available), final analysis and other information relevant to the conduct of the Study. In addition to a Project Manager, each Party shall designate an alliance manager (the “Alliance Manager”), who shall endeavor to ensure clear and responsive communication between the Parties and the effective exchange of information, and shall serve as the primary point of contact for any issues arising under this Agreement. The Alliance Managers shall have the right to attend all JDC meetings and may bring to the attention of the JDC any matters or issues either of them reasonably believes should be discussed, and shall have such other responsibilities as the Parties may mutually agree in writing. In the event that an issue arises and the Alliance Managers cannot or do not, after good faith efforts, reach agreement on such issue, the issue shall be elevated to the Head of Clinical Oncology for Merck and the Vice President of Medical Affairs or Business Development for BioLineRx.

  • Voting Provisions Regarding Board of Directors 1.1 For purposes of this Agreement, the term “

Time is Money Join Law Insider Premium to draft better contracts faster.